Last viewed: ELOX


Prices are updated after-hours



nasdaq:ELOX Eloxx Pharmaceuticals, Inc.

ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-51.4% 1m) (-89.0% 1y) (0.0% 2d) (0.0% 3d) (12.2% 7d) (29.53% volume)
Earnings Calendar: 2022-08-15
Market Cap: $ 14,861,542

http://www.eloxxpharma.com
Sec Filling | Patents | 29 employees


(US) Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. It operates through the United States and Israel geographical segments. Its product includes ELX-02, a small molecule drug designed to restore production of full-length functional proteins which treats cystic fibrosis and cystinosis. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Waltham, MA.

israel   fibrosis   molecule drugs  

add to watch list email alert is off

Press-releases


Eloxx Pharmaceuticals Reports Topline Results from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis (CF) Patients
Published: 2022-09-14 (Crawled : 21:00) - biospace.com/
ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology
| | O: 4.99% H: 5.53% C: -4.52%

elx-02 fibrosis topline trial results
Eloxx Pharmaceuticals Reports Second Quarter 2022 Financial and Operating Results and Provides Business Update
Published: 2022-08-15 (Crawled : 14:00) - biospace.com/
ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology
| | O: 22.4% H: 4.64% C: 4.17%

update results
Eloxx Pharmaceuticals Announces Changes to Board of Directors
Published: 2022-07-05 (Crawled : 14:00) - biospace.com/
ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology
| | O: -4.51% H: 16.69% C: 12.3%


Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update
Published: 2022-05-10 (Crawled : 15:20) - globenewswire.com
ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology
| | O: 5.72% H: 0.0% C: -13.68%

update results
Eloxx Pharmaceuticals Reports Fourth Quarter 2021 Financial and Operating Results and Provides Business Update
Published: 2022-03-31 (Crawled : 15:20) - globenewswire.com
ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology
| | O: 1.4% H: 1.74% C: -3.47%

update results
Eloxx Pharmaceuticals Announces New Development Program for ELX-02 for the Treatment of Alport Syndrome
Published: 2022-03-30 (Crawled : 21:00) - biospace.com/
ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology
| | O: 3.46% H: 7.77% C: 6.32%

elx-02 treatment program for
Eloxx Pharmaceuticals Announces Therapeutic Development Award from Cystic Fibrosis Foundation
Published: 2022-03-29 (Crawled : 12:20) - biospace.com/
ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology
| | O: 2.08% H: 12.22% C: 6.12%

fibrosis therapeutics awards
Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2 Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients
Published: 2021-11-17 (Crawled : 13:00) - biospace.com/
ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology
| | O: -10.55% H: 2.83% C: -18.11%

phase 2 fibrosis positive therapy results topline trial elx-02
Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update
Published: 2021-11-09 (Crawled : 13:00) - globenewswire.com
HTGC | $12.61 8.61% 0.0% | twitter stocktwits trandingview |
Finance
| | O: -2.9% H: 0.0% C: 0.0%
ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology
| | O: 2.88% H: 1.4% C: -2.8%

results
Eloxx Pharmaceuticals to Host Investor and Analyst Call and Webcast on Cystic Fibrosis Programs
Published: 2021-10-07 (Crawled : 00:00) - globenewswire.com
ELOX | $0.1715 0.88% 7.87% | twitter stocktwits trandingview |
Health Technology
| | O: 3.85% H: 2.47% C: -1.85%

fibrosis
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount
0001104659-22-077837 4 2022-07-07 2022-07-01 Buy A 40000 40000


Your Today's Watch List
Sign in to create a watchlist
Top 10 Gainers
VEV | $1.07 5.42% 59.81% | twitter stocktwits trandingview |
Manufacturing

HCKT | News | $19.22 4.86% 49.17% | twitter stocktwits trandingview |
Commercial Services

PEGY J | $1.43 79.69% 30.77% | twitter stocktwits trandingview |
Manufacturing

TOPS | $5.43 66.05% 25.23% | twitter stocktwits trandingview |
Transportation

AREB | $0.4294 19.28% 18.77% | twitter stocktwits trandingview |
Manufacturing

UNCY | $0.5559 -7.35% 16.93% | twitter stocktwits trandingview |
Professional, Scientific, and T...

SABS | $0.77 2.68% 16.88% | twitter stocktwits trandingview |

ALYA | $1.97 3.14% 16.5% | twitter stocktwits trandingview |
Technology Services

STSS 4 | $1.3 10.17% 16.15% | twitter stocktwits trandingview |
n/a

LIQT | $0.3901 0.54% 15.35% | twitter stocktwits trandingview |
Producer Manufacturing


Last 48 Hours Insiders Buying
UTG P 400 | $34.13 0% | twitter stocktwits trandingview |
Miscellaneous
| 18:00

12 months watchlist earnings calendar